Association of serum uric acid levels with benign prostatic hyperplasia in US men: results from NHANES 2005–2008

References

• Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia – What do we know? BJU Int. 2021;127(4):389–399. doi: 10.1111/bju.15229.
   PubMed Web of Science ®Google Scholar
• Lu Y, Fan S, Song Y, et al. The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men. World J Urol. 2021;39(7):2645–2653. doi: 10.1007/s00345-020-03511-6.
   PubMed Web of Science ®Google Scholar
• Zhu C, Wang DQ, Zi H, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res. 2021;8(1):64. doi: 10.1186/s40779-021-00359-8.
   PubMed Web of Science ®Google Scholar
• Egan KB, Suh M, Rosen RC, et al. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008. Int J Clin Pract. 2015;69(11):1316–1325. doi: 10.1111/ijcp.12709.
   PubMed Web of Science ®Google Scholar
• Vignozzi L, Gacci M, Maggi M. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol. 2016;13(2):108–119. doi: 10.1038/nrurol.2015.301.
   PubMed Web of Science ®Google Scholar
• Wang JY, Fu YY, Kang DY. The association between metabolic syndrome and characteristics of benign prostatic hyperplasia: a systematic review and Meta-Analysis. Medicine. 2016;95(19):e3243. doi: 10.1097/md.0000000000003243.
   PubMed Web of Science ®Google Scholar
• Cirillo P, Sato W, Reungjui S, et al. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol. 2006;17(12 Suppl 3):S165–S8. doi: 10.1681/asn.2006080909.
   PubMed Web of Science ®Google Scholar
• Tsouli SG, Liberopoulos EN, Mikhailidis DP, et al. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism. 2006;55(10):1293–1301. doi: 10.1016/j.metabol.2006.05.013.
   PubMed Web of Science ®Google Scholar
• Li WM, Pasaribu N, Lee SS, et al. Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study. Prostate Cancer Prostatic Dis. 2018;21(2):277–286. doi: 10.1038/s41391-018-0047-8.
   PubMed Web of Science ®Google Scholar
• Siroosbakht S, Rezakhaniha S, Namdari F, et al. Is there relationship between serum uric acid levels and lower urinary tract symptoms, prostate volume, and PSA in men without cancer? A prospective population-based study. Andrologia. 2021;53(10):e14200. doi: 10.1111/and.14200.
   PubMed Web of Science ®Google Scholar
• Hwang J, Ryu S, Ahn JK. Higher levels of serum uric acid have a significant association with lower incidence of lower urinary tract symptoms in healthy korean men. Metabolites. 2022;12(7):649. doi: 10.3390/metabo12070649.
   PubMed Web of Science ®Google Scholar
• So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120(6):1791–1799. doi: 10.1172/jci42344.
   PubMed Web of Science ®Google Scholar
• Yang L, Liu Z, Peng Z, et al. Exposure to Di-2-ethylhexyl phthalate and benign prostatic hyperplasia, NHANES 2001–2008. Front Endocrinol. 2021;12:804457. doi: 10.3389/fendo.2021.804457.
   PubMed Web of Science ®Google Scholar
• Nguyen S, Choi HK, Lustig RH, et al. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr. 2009;154(6):807–813. doi: 10.1016/j.jpeds.2009.01.015.
   PubMed Web of Science ®Google Scholar
• Wang W, Xiang LY, Ma YC, et al. The association between heavy metal exposure and erectile dysfunction in the United States. Asian J Androl. 2023;25(2):271–276. doi: 10.4103/aja202237.
   PubMed Web of Science ®Google Scholar
• Speakman M, Kirby R, Doyle S, et al. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) – focus on the UK. BJU Int. 2015;115(4):508–519. doi: 10.1111/bju.12745.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang Y, Cao Y, et al. Exploration of the association between serum uric acid and testosterone in adult males: NHANES 2011-2016. Transl Androl Urol. 2021;10(1):272–282. doi: 10.21037/tau-20-1114.
   PubMed Web of Science ®Google Scholar
• Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–1821. doi: 10.1056/NEJMra0800885.
   PubMed Web of Science ®Google Scholar
• Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894–900. doi: 10.1161/circulationaha.107.703389.
   PubMed Web of Science ®Google Scholar
• Song JU, Hwang J, Ahn JK. Serum uric acid is positively associated with pulmonary function in Korean health screening examinees. Mod Rheumatol. 2017;27(6):1057–1065. doi: 10.1080/14397595.2017.1285981.
   PubMed Web of Science ®Google Scholar
• Hwang J, Hwang JH, Ryu S, et al. Higher serum uric acid is associated with higher lumbar spine bone mineral density in male health-screening examinees: a cross-sectional study. J Bone Miner Metab. 2019;37(1):142–151. doi: 10.1007/s00774-018-0905-4.
   PubMed Web of Science ®Google Scholar
• Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981;78(11):6858–6862. doi: 10.1073/pnas.78.11.6858.
   PubMed Web of Science ®Google Scholar
• Kühn T, Sookthai D, Graf ME, et al. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer. 2017;117(10):1572–1579. doi: 10.1038/bjc.2017.313.
   PubMed Web of Science ®Google Scholar
• Taghizadeh N, Vonk JM, Boezen HM. Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study. Cancer Causes Control. 2014;25(8):1075–1080. doi: 10.1007/s10552-014-0408-0.
   PubMed Web of Science ®Google Scholar
• Sangkop F, Singh G, Rodrigues E, et al. Uric acid: a modulator of prostate cells and activin sensitivity. Mol Cell Biochem. 2016;414(1–2):187–199. doi: 10.1007/s11010-016-2671-8.
   PubMed Web of Science ®Google Scholar
• Afify H, Abo-Youssef AM, Abdel-Rahman HM, et al. The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia. Toxicol Appl Pharmacol. 2020;402:115122. doi: 10.1016/j.taap.2020.115122.
   PubMed Web of Science ®Google Scholar
• Wang A, Barber JR, Tin A, et al. Serum urate, genetic variation, and prostate cancer risk: atherosclerosis risk in communities (ARIC) study. Cancer Epidemiol Biomarkers Prev. 2019;28(7):1259–1261. doi: 10.1158/1055-9965.Epi-19-0161.
   PubMed Web of Science ®Google Scholar
• Meng J, Zhang M, Guan SY, et al. The prevalence and risk factors of prostatic calculi in Han Chinese: a cross-sectional study based on health examinations. Aging Male. 2020;23(5):887–892. doi: 10.1080/13685538.2019.1620203.
   PubMed Web of Science ®Google Scholar
• Balasar M, Sönmez MG, Aydın A, et al. Is there a relation between serum uric acid values and prostatic calculi presence? Urol Int. 2019;102(2):199–204. doi: 10.1159/000495313.
   PubMed Web of Science ®Google Scholar